These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11720063)

  • 1. Pharmaceutical industry-sponsored meetings: good value or just a free meal?
    Carney SL; Nair KR; Sales MA; Walsh J
    Intern Med J; 2001 Nov; 31(8):488-91. PubMed ID: 11720063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
    Rutledge P; Crookes D; McKinstry B; Maxwell SR
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuing medical education and pharmaceutical industry involvement: An evaluation of policies adopted by Canadian professional medical associations.
    Shnier A; Lexchin J
    Int J Risk Saf Med; 2017; 29(1-2):1-16. PubMed ID: 28885217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative evaluation of sponsored and unsponsored continuing medical education].
    Chon SH; Lösche P; Christ H; Lehmacher W; Griebenow R
    Med Klin (Munich); 2008 May; 103(5):341-5. PubMed ID: 18484220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuing education for general practice and the role of the pharmaceutical industry.
    Hayes TM; Allery LA; Harding KG; Owen PA
    Br J Gen Pract; 1990 Dec; 40(341):510-2. PubMed ID: 2282231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
    Rosner F
    Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physicians and drug industry: attitudes and practice].
    Aasland OG; Førde R
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Funding sources for continuing medical education: An observational study.
    Venkataraman R; Ranganathan L; Ponnish AS; Abraham BK; Ramakrishnan N
    Indian J Crit Care Med; 2014 Aug; 18(8):513-7. PubMed ID: 25136190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician preferences and attitudes regarding industry support of CME programs.
    Mueller PS; Hook CC; Litin SC
    Am J Med; 2007 Mar; 120(3):281-5. PubMed ID: 17349454
    [No Abstract]   [Full Text] [Related]  

  • 11. Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia.
    Lee YC; Kroon R; Koczwara B; Haines I; Francis K; Millward M; Kefford R; Olver I; Mileshkin L
    Intern Med J; 2017 Aug; 47(8):888-893. PubMed ID: 28485058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conflict of interest in continuing medical education - Studies on certified CME courses].
    Lenzen LM; Weidringer JW; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the value of commercially supported CME.
    Miller LA
    J Contin Educ Health Prof; 2009; 29(1):68-70. PubMed ID: 19288557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commercial Interests in Continuing Medical Education: Where Do Electronic Health Record Vendors Fit?
    Rubinstein PF; Middleton B; Goodman KW; Lehmann CU
    Acad Med; 2020 Nov; 95(11):1674-1678. PubMed ID: 32079950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The consequences of diminishing industry support on the independent education landscape: an evidence-based analysis of the perceived and realistic impact on professional development and patient care among oncologists.
    Robinson C; Ruggiero J; Abdolrasulnia M; Burton BS
    J Cancer Educ; 2015 Mar; 30(1):75-80. PubMed ID: 24781931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The uncertain future of continuing medical education: commercialism and shifts in funding.
    Van Harrison R
    J Contin Educ Health Prof; 2003; 23(4):198-209. PubMed ID: 14730790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CME, physicians, and Pavlov: can we change what happens when industry rings the bell?
    Lichter PR
    Trans Am Ophthalmol Soc; 2008; 106():39-43; discussion 44-5. PubMed ID: 19277219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of industry support on participants' perceptions of bias in continuing medical education.
    Kawczak S; Carey W; Lopez R; Jackman D
    Acad Med; 2010 Jan; 85(1):80-4. PubMed ID: 20042829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does locally delivered small group continuing medical education (CME) meet the learning needs of rural general practitioners?
    Dowling S; Last J; Finnegan H; O'Connor K; Cullen W
    Educ Prim Care; 2019 May; 30(3):145-151. PubMed ID: 30747043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.